** Brokerage UBS downgrades life and health reinsurer Reinsurance Group of America RGA.N to "neutral" from "buy"; cuts PT to $216 from $250
** Cites execution risk on annual capital deployment target as well as on the Equitable Holdings EQH.N deal
** Says the recent overhang on shares to persist over the near term as management executes its newer, more aggressive growth strategy
** "Reliance on 3rd party capital to meet EPS growth can be seen as "stretching" for a global reinsurance franchise historically known for its conservativism," says brokerage
** Nine of 12 brokerages rate stock "buy" or higher, and 3 "hold"; median PT is $250 — LSEG data
** Including session moves, RGA stock down ~6.7% YTD, compared to a 4.2% decline in the S&P 500 .SPX
(Reporting by Ateev Bhandari in Bengaluru)
((Ateev.Bhandari@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.